Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio Elkis

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
JAMA Psychiatry|October 17, 2019
Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical TrialLeandro da Costa Lane Valiengo, Stephan Goerigk, Pedro Caldana Gordon, et al.
Comprehensive Psychiatry|July 4, 2018
The Brief Negative Symptom Scale: Validation in a multicenter Brazilian studyHeydrich Lopes Virgulino de Medeiros, Selene Cordeiro Vasconcelos, Helio Elkis, et al.
Schizophrenia Research|December 16, 2014
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophreniaCristiano Chaves, Cristiane R Marque, João P Maia-de-Oliveira, et al.
Schizophrenia Research|September 4, 2021
Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrificationPedro Gomes Penteado Rosa, Andre Zugman, Carlos Toledo Cerqueira, et al.
Neuroimage. Clinical|June 30, 2016
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illnessUlysses S Torres, Fabio L S Duran, Maristela S Schaufelberger, et al.
The American Journal of Psychiatry|June 6, 2015
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test ReviewMyrto T Samara, Claudia Leucht, Mariska M Leeflang, et al.
The American Journal of Psychiatry|December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver D Howes, Rob McCutcheon, Ofer Agid, et al.
Annals of Internal Medicine|October 17, 2022
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysisGeorgia Salanti, Natalie Peter, Thomy Tonia, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Pharmacopsychiatry|December 15, 2021
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
JAMA Psychiatry|October 17, 2019
Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical TrialLeandro da Costa Lane Valiengo, Stephan Goerigk, Pedro Caldana Gordon, et al.
Comprehensive Psychiatry|July 4, 2018
The Brief Negative Symptom Scale: Validation in a multicenter Brazilian studyHeydrich Lopes Virgulino de Medeiros, Selene Cordeiro Vasconcelos, Helio Elkis, et al.
Schizophrenia Research|December 16, 2014
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophreniaCristiano Chaves, Cristiane R Marque, João P Maia-de-Oliveira, et al.
Schizophrenia Research|September 4, 2021
Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrificationPedro Gomes Penteado Rosa, Andre Zugman, Carlos Toledo Cerqueira, et al.
Neuroimage. Clinical|June 30, 2016
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illnessUlysses S Torres, Fabio L S Duran, Maristela S Schaufelberger, et al.
The American Journal of Psychiatry|June 6, 2015
Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test ReviewMyrto T Samara, Claudia Leucht, Mariska M Leeflang, et al.
The American Journal of Psychiatry|December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver D Howes, Rob McCutcheon, Ofer Agid, et al.
Annals of Internal Medicine|October 17, 2022
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysisGeorgia Salanti, Natalie Peter, Thomy Tonia, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Pharmacopsychiatry|December 15, 2021
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Pageof 7